STOCK TITAN

Saba Capital reports 10% stake in Sharps Technology (STSS) ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Saba Capital Management, L.P. has filed an initial ownership report as a 10% owner of Sharps Technology Inc. (STSS) as of 01/09/2026. The filing shows indirect beneficial ownership of 1,656,635 shares of common stock.

Saba Capital also indirectly holds cash stapled warrants exercisable into 1,538,462 shares of common stock at an exercise price of $9.75, expiring on 11/04/2028, and pre-funded warrants for 388,462 shares of common stock at $6.50 per share, noted as expiring when exercised in full.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Saba Capital Management, L.P.

(Last) (First) (Middle)
405 LEXINGTON AVENUE
58TH FLOOR

(Street)
NEW YORK NY 10174

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/09/2026
3. Issuer Name and Ticker or Trading Symbol
Sharps Technology Inc. [ STSS ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 1,656,635 I -
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Cash Stapled Warrants 01/08/2026 11/04/2028 Common Stock 1,538,462 $9.75 I -
Pre-Funded Warrants 11/04/2025 (1) Common Stock 388,462 $6.5 I -
Explanation of Responses:
1. These warrants expire when exercised in full.
Saba Capital Management, L.P. By: Zachary Gindes 01/15/2026
Boaz Weinstein 01/15/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Form 3 filing for STSS by Saba Capital show?

The Form 3 shows Saba Capital Management, L.P. as a 10% owner of Sharps Technology Inc. (STSS), reporting indirect beneficial ownership of common stock and warrants.

How many Sharps Technology (STSS) common shares does Saba Capital report?

Saba Capital reports indirect beneficial ownership of 1,656,635 shares of Sharps Technology common stock as of 01/09/2026.

What cash stapled warrants on STSS does Saba Capital hold?

Saba Capital indirectly holds cash stapled warrants for 1,538,462 shares of Sharps Technology common stock with an exercise price of $9.75, expiring on 11/04/2028.

What pre-funded warrants on STSS are reported in the Form 3?

The filing reports pre-funded warrants indirectly held for 388,462 shares of Sharps Technology common stock at an exercise price of $6.50 per share, which expire when exercised in full.

Is Saba Capital’s ownership in STSS direct or indirect?

All reported positions in the filing, including common stock, cash stapled warrants, and pre-funded warrants, are listed with indirect (I) beneficial ownership.

Does the Form 3 indicate any transactions or only holdings for STSS?

The Form 3 reflects holdings as of 01/09/2026 in common stock and warrants for Sharps Technology rather than reporting new purchase or sale transactions.
Sharps Tech

NASDAQ:STSS

STSS Rankings

STSS Latest News

STSS Latest SEC Filings

STSS Stock Data

66.69M
28.19M
0.08%
0.07%
2.79%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE